Zhejiang Taimei Medical Technology Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 2576?
Owner Type	Number of Shares	Ownership Percentage
Employee Share Scheme	39,657,056	7.03%
Institutions	68,303,998	12.1%
General Public	77,489,519	13.7%
Private Companies	82,479,676	14.6%
VC/PE Firms	140,004,816	24.8%
Individual Insiders	155,843,935	27.6%

Dilution of Shares: 2576 only recently listed within the past 12 months

Top Shareholders

Top 25 shareholders own 85.72% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
19.7%	Zhao Lu	111,247,232	HK$558.5m	0%	no data
9.95%	Linzhi Tencent Investment Management Co., Ltd.	56,101,026	HK$281.6m	0%	no data
8.95%	Jingwei Venture Capital (Beijing) Investment Management Consulting Co., Ltd.	50,450,412	HK$253.3m	0%	19.95%
7.03%	Zhejiang Taimei Medical Technology Co., Ltd, ESOP	39,657,056	HK$199.1m	0%	no data
5.93%	Suzhou Kaifeng Housheng Venture Capital Management Center (GP)	33,453,378	HK$167.9m	0%	100.0%
3.67%	Shanghai Xingpan Investment Management Consulting Co., Ltd.	20,673,188	HK$103.8m	0%	no data
3.58%	Zheshang Venture Capital Co., Ltd	20,188,450	HK$101.3m	0%	24.96%
3.26%	Suzhou SAIF Puxin Medical and Health Industry Investment Center (Limited Partnership)	18,368,552	HK$92.2m	0%	no data
3.23%	Xinyu Shenkong Enterprise Management Partnership (Limited Partnership)	18,204,844	HK$91.4m	0%	no data
3.06%	Meng Tang	17,270,338	HK$86.7m	0%	no data
2.48%	Xinyu Haolin Enterprise Management Partnership (Limited Partnership)	13,974,550	HK$70.2m	0%	no data
2.4%	Ningbo Free Trade Zone Kaifeng Venture Capital Management Co., Ltd.	13,502,724	HK$67.8m	0%	no data
2.22%	Xu Zhang	12,491,284	HK$62.7m	0%	no data
1.8%	Hongwei Zhang	10,139,955	HK$50.9m	0%	no data
1.7%	SB China Venture Capital	9,564,620	HK$48.0m	0%	22.49%
1.03%	Suzhou Songyuan Entrepreneurship Investment Managment Co Ltd	5,790,494	HK$29.1m	0%	no data
1.03%	Suzhou Northern Lights Hongyuan Venture Capital Partnership (Limited Partnership)	5,790,494	HK$29.1m	0%	no data
0.95%	Zhoushan Yijin Investment Management Partnership (Limited Partnership) ("Zhoushan Yijin")	5,380,538	HK$27.0m	0%	no data
0.71%	Shanghai Jingwei Equity Investment Management Co.,Ltd.	4,023,164	HK$20.2m	0%	no data
0.64%	Xinyu Qiwushi Medical Technology Partnership Enterprise (Limited Partnership)	3,620,740	HK$18.2m	0%	no data
0.62%	Lingye Zuo	3,520,134	HK$17.7m	0%	no data
0.57%	5Y Capital	3,200,024	HK$16.1m	0%	0.37%
0.43%	Xinyu Taimei Xingmeng Enterprise Management Partnership (Limited Partnership)	2,433,000	HK$12.2m	0%	no data
0.41%	Xinyu Ruansu Enterprise Management Partnership (Limited Partnership)	2,293,494	HK$11.5m	0%	no data
0.34%	Ningbo Xuri Xinzhu Investment Partnership Enterprise (Limited Partnership)	1,929,806	HK$9.7m	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/21 23:52
End of Day Share Price	2024/12/20 00:00
Earnings	2024/03/31
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Zhejiang Taimei Medical Technology Co., Ltd. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Yang Liu	Morgan Stanley